New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
/PRNewswire/ The "Life Science Tools: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global Life Science.